カテゴリ： 世界, 医療/バイオ, Market Monitor Global

グリコサミノコンドロイチン・サプリメントのグローバル市場展望 2023年-2029年：カプセル、錠剤、その他

■ 英語タイトル：Glycosaminochondroitin Supplements Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14349）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14349
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：124
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[グリコサミノコンドロイチン・サプリメントのグローバル市場展望 2023年-2029年：カプセル、錠剤、その他]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のグリコサミノコンドロイチン・サプリメント市場規模と予測を収録しています。・世界のグリコサミノコンドロイチン・サプリメント市場：売上、2018年-2023年、2024年-2029年
・世界のグリコサミノコンドロイチン・サプリメント市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のグリコサミノコンドロイチン・サプリメント市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「カプセル」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

グリコサミノコンドロイチン・サプリメントのグローバル主要企業は、Suntory、 Orihiro Group、 ANXIN、 WanTuMing Biological、 TSI Group、 Yantai Dongcheng、 Focus Chem、 YBCC、 Runxin Biotechnology、 ISBA、 Huiwen、 QJBCHINA、 Meitek(Synutra International)、 Hengjie Bio-Pharmaceuticals、 Nippon Zoki、 GGI、 Summit Nutritionals、 Sioux Pharm、 Ruikangda Biochemical、 Guanglong Biochem、 Pacific Rainbow、 Summit Nutritionals International、 Webber Naturals、 Mannings、 Life Extension、 Schiff、 Doctor's Best、 Osteo Bi-Flex、 Kirklandなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、グリコサミノコンドロイチン・サプリメントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のグリコサミノコンドロイチン・サプリメント市場：タイプ別、2018年-2023年、2024年-2029年
世界のグリコサミノコンドロイチン・サプリメント市場：タイプ別市場シェア、2022年
・カプセル、錠剤、その他

世界のグリコサミノコンドロイチン・サプリメント市場：用途別、2018年-2023年、2024年-2029年
世界のグリコサミノコンドロイチン・サプリメント市場：用途別市場シェア、2022年
・薬局、スーパーマーケット、その他

世界のグリコサミノコンドロイチン・サプリメント市場：地域・国別、2018年-2023年、2024年-2029年
世界のグリコサミノコンドロイチン・サプリメント市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるグリコサミノコンドロイチン・サプリメントのグローバル売上、2018年-2023年
・主要企業におけるグリコサミノコンドロイチン・サプリメントのグローバル売上シェア、2022年
・主要企業におけるグリコサミノコンドロイチン・サプリメントのグローバル販売量、2018年-2023年
・主要企業におけるグリコサミノコンドロイチン・サプリメントのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Suntory、 Orihiro Group、 ANXIN、 WanTuMing Biological、 TSI Group、 Yantai Dongcheng、 Focus Chem、 YBCC、 Runxin Biotechnology、 ISBA、 Huiwen、 QJBCHINA、 Meitek(Synutra International)、 Hengjie Bio-Pharmaceuticals、 Nippon Zoki、 GGI、 Summit Nutritionals、 Sioux Pharm、 Ruikangda Biochemical、 Guanglong Biochem、 Pacific Rainbow、 Summit Nutritionals International、 Webber Naturals、 Mannings、 Life Extension、 Schiff、 Doctor's Best、 Osteo Bi-Flex、 Kirkland

*************************************************************

・調査・分析レポートの概要
グリコサミノコンドロイチン・サプリメント市場の定義
市場セグメント
世界のグリコサミノコンドロイチン・サプリメント市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のグリコサミノコンドロイチン・サプリメント市場規模
世界のグリコサミノコンドロイチン・サプリメント市場規模：2022年 VS 2029年
世界のグリコサミノコンドロイチン・サプリメント市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのグリコサミノコンドロイチン・サプリメントの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のグリコサミノコンドロイチン・サプリメント製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：カプセル、錠剤、その他
グリコサミノコンドロイチン・サプリメントのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：薬局、スーパーマーケット、その他
グリコサミノコンドロイチン・サプリメントの用途別グローバル売上・予測

・地域別市場分析
地域別グリコサミノコンドロイチン・サプリメント市場規模 2022年と2029年
地域別グリコサミノコンドロイチン・サプリメント売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Suntory、 Orihiro Group、 ANXIN、 WanTuMing Biological、 TSI Group、 Yantai Dongcheng、 Focus Chem、 YBCC、 Runxin Biotechnology、 ISBA、 Huiwen、 QJBCHINA、 Meitek(Synutra International)、 Hengjie Bio-Pharmaceuticals、 Nippon Zoki、 GGI、 Summit Nutritionals、 Sioux Pharm、 Ruikangda Biochemical、 Guanglong Biochem、 Pacific Rainbow、 Summit Nutritionals International、 Webber Naturals、 Mannings、 Life Extension、 Schiff、 Doctor's Best、 Osteo Bi-Flex、 Kirkland
...

This research report provides a comprehensive analysis of the Glycosaminochondroitin Supplements market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Glycosaminochondroitin Supplements market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Glycosaminochondroitin Supplements, challenges faced by the industry, and potential opportunities for market players.
The global Glycosaminochondroitin Supplements market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Glycosaminochondroitin Supplements market presents opportunities for various stakeholders, including Pharmacy, Supermarket. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Glycosaminochondroitin Supplements market. Additionally, the growing consumer demand present avenues for market expansion.
The global Glycosaminochondroitin Supplements market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
The aging population worldwide is driving the demand for joint health supplements, including glycosaminoglycan supplements. As people age, they are more likely to experience joint-related issues, such as osteoarthritis. There is a growing awareness of the importance of joint health and preventive healthcare, leading more consumers to seek out supplements like glucosamine and chondroitin. The rise of e-commerce has made it easier for consumers to access a wide range of dietary supplements, including GAG supplements, contributing to market growth.
Key Features:
The research report on the Glycosaminochondroitin Supplements market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Glycosaminochondroitin Supplements market.
Market Overview: The report provides a comprehensive overview of the Glycosaminochondroitin Supplements market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Capsule, Tablet), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Glycosaminochondroitin Supplements market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Glycosaminochondroitin Supplements market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Glycosaminochondroitin Supplements market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Glycosaminochondroitin Supplements market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Glycosaminochondroitin Supplements market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Glycosaminochondroitin Supplements market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Glycosaminochondroitin Supplements, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Glycosaminochondroitin Supplements market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Glycosaminochondroitin Supplements market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Capsule
Tablet
Others
Market segment by Application
Pharmacy
Supermarket
Others
Global Glycosaminochondroitin Supplements Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Suntory
Orihiro Group
ANXIN
WanTuMing Biological
TSI Group
Yantai Dongcheng
Focus Chem
YBCC
Runxin Biotechnology
ISBA
Huiwen
QJBCHINA
Meitek(Synutra International)
Hengjie Bio-Pharmaceuticals
Nippon Zoki
GGI
Summit Nutritionals
Sioux Pharm
Ruikangda Biochemical
Guanglong Biochem
Pacific Rainbow
Summit Nutritionals International
Webber Naturals
Mannings
Life Extension
Schiff
Doctor’s Best
Osteo Bi-Flex
Kirkland
Outline of Major Chapters:
Chapter 1: Introduces the definition of Glycosaminochondroitin Supplements, market overview.
Chapter 2: Global Glycosaminochondroitin Supplements market size in revenue and volume.
Chapter 3: Detailed analysis of Glycosaminochondroitin Supplements manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Glycosaminochondroitin Supplements in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Glycosaminochondroitin Supplements capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Glycosaminochondroitin Supplements Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Glycosaminochondroitin Supplements Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Glycosaminochondroitin Supplements Overall Market Size
2.1 Global Glycosaminochondroitin Supplements Market Size: 2022 VS 2029
2.2 Global Glycosaminochondroitin Supplements Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Glycosaminochondroitin Supplements Sales: 2018-2029
3 Company Landscape
3.1 Top Glycosaminochondroitin Supplements Players in Global Market
3.2 Top Global Glycosaminochondroitin Supplements Companies Ranked by Revenue
3.3 Global Glycosaminochondroitin Supplements Revenue by Companies
3.4 Global Glycosaminochondroitin Supplements Sales by Companies
3.5 Global Glycosaminochondroitin Supplements Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Glycosaminochondroitin Supplements Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Glycosaminochondroitin Supplements Product Type
3.8 Tier 1, Tier 2 and Tier 3 Glycosaminochondroitin Supplements Players in Global Market
3.8.1 List of Global Tier 1 Glycosaminochondroitin Supplements Companies
3.8.2 List of Global Tier 2 and Tier 3 Glycosaminochondroitin Supplements Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Glycosaminochondroitin Supplements Market Size Markets, 2022 & 2029
4.1.2 Capsule
4.1.3 Tablet
4.1.4 Others
4.2 By Type – Global Glycosaminochondroitin Supplements Revenue & Forecasts
4.2.1 By Type – Global Glycosaminochondroitin Supplements Revenue, 2018-2023
4.2.2 By Type – Global Glycosaminochondroitin Supplements Revenue, 2024-2029
4.2.3 By Type – Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
4.3 By Type – Global Glycosaminochondroitin Supplements Sales & Forecasts
4.3.1 By Type – Global Glycosaminochondroitin Supplements Sales, 2018-2023
4.3.2 By Type – Global Glycosaminochondroitin Supplements Sales, 2024-2029
4.3.3 By Type – Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
4.4 By Type – Global Glycosaminochondroitin Supplements Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Glycosaminochondroitin Supplements Market Size, 2022 & 2029
5.1.2 Pharmacy
5.1.3 Supermarket
5.1.4 Others
5.2 By Application – Global Glycosaminochondroitin Supplements Revenue & Forecasts
5.2.1 By Application – Global Glycosaminochondroitin Supplements Revenue, 2018-2023
5.2.2 By Application – Global Glycosaminochondroitin Supplements Revenue, 2024-2029
5.2.3 By Application – Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
5.3 By Application – Global Glycosaminochondroitin Supplements Sales & Forecasts
5.3.1 By Application – Global Glycosaminochondroitin Supplements Sales, 2018-2023
5.3.2 By Application – Global Glycosaminochondroitin Supplements Sales, 2024-2029
5.3.3 By Application – Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
5.4 By Application – Global Glycosaminochondroitin Supplements Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Glycosaminochondroitin Supplements Market Size, 2022 & 2029
6.2 By Region – Global Glycosaminochondroitin Supplements Revenue & Forecasts
6.2.1 By Region – Global Glycosaminochondroitin Supplements Revenue, 2018-2023
6.2.2 By Region – Global Glycosaminochondroitin Supplements Revenue, 2024-2029
6.2.3 By Region – Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
6.3 By Region – Global Glycosaminochondroitin Supplements Sales & Forecasts
6.3.1 By Region – Global Glycosaminochondroitin Supplements Sales, 2018-2023
6.3.2 By Region – Global Glycosaminochondroitin Supplements Sales, 2024-2029
6.3.3 By Region – Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Glycosaminochondroitin Supplements Revenue, 2018-2029
6.4.2 By Country – North America Glycosaminochondroitin Supplements Sales, 2018-2029
6.4.3 US Glycosaminochondroitin Supplements Market Size, 2018-2029
6.4.4 Canada Glycosaminochondroitin Supplements Market Size, 2018-2029
6.4.5 Mexico Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Glycosaminochondroitin Supplements Revenue, 2018-2029
6.5.2 By Country – Europe Glycosaminochondroitin Supplements Sales, 2018-2029
6.5.3 Germany Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.4 France Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.5 U.K. Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.6 Italy Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.7 Russia Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.8 Nordic Countries Glycosaminochondroitin Supplements Market Size, 2018-2029
6.5.9 Benelux Glycosaminochondroitin Supplements Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Glycosaminochondroitin Supplements Revenue, 2018-2029
6.6.2 By Region – Asia Glycosaminochondroitin Supplements Sales, 2018-2029
6.6.3 China Glycosaminochondroitin Supplements Market Size, 2018-2029
6.6.4 Japan Glycosaminochondroitin Supplements Market Size, 2018-2029
6.6.5 South Korea Glycosaminochondroitin Supplements Market Size, 2018-2029
6.6.6 Southeast Asia Glycosaminochondroitin Supplements Market Size, 2018-2029
6.6.7 India Glycosaminochondroitin Supplements Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Glycosaminochondroitin Supplements Revenue, 2018-2029
6.7.2 By Country – South America Glycosaminochondroitin Supplements Sales, 2018-2029
6.7.3 Brazil Glycosaminochondroitin Supplements Market Size, 2018-2029
6.7.4 Argentina Glycosaminochondroitin Supplements Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Glycosaminochondroitin Supplements Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Glycosaminochondroitin Supplements Sales, 2018-2029
6.8.3 Turkey Glycosaminochondroitin Supplements Market Size, 2018-2029
6.8.4 Israel Glycosaminochondroitin Supplements Market Size, 2018-2029
6.8.5 Saudi Arabia Glycosaminochondroitin Supplements Market Size, 2018-2029
6.8.6 UAE Glycosaminochondroitin Supplements Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Suntory
7.1.1 Suntory Company Summary
7.1.2 Suntory Business Overview
7.1.3 Suntory Glycosaminochondroitin Supplements Major Product Offerings
7.1.4 Suntory Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.1.5 Suntory Key News & Latest Developments
7.2 Orihiro Group
7.2.1 Orihiro Group Company Summary
7.2.2 Orihiro Group Business Overview
7.2.3 Orihiro Group Glycosaminochondroitin Supplements Major Product Offerings
7.2.4 Orihiro Group Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.2.5 Orihiro Group Key News & Latest Developments
7.3 ANXIN
7.3.1 ANXIN Company Summary
7.3.2 ANXIN Business Overview
7.3.3 ANXIN Glycosaminochondroitin Supplements Major Product Offerings
7.3.4 ANXIN Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.3.5 ANXIN Key News & Latest Developments
7.4 WanTuMing Biological
7.4.1 WanTuMing Biological Company Summary
7.4.2 WanTuMing Biological Business Overview
7.4.3 WanTuMing Biological Glycosaminochondroitin Supplements Major Product Offerings
7.4.4 WanTuMing Biological Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.4.5 WanTuMing Biological Key News & Latest Developments
7.5 TSI Group
7.5.1 TSI Group Company Summary
7.5.2 TSI Group Business Overview
7.5.3 TSI Group Glycosaminochondroitin Supplements Major Product Offerings
7.5.4 TSI Group Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.5.5 TSI Group Key News & Latest Developments
7.6 Yantai Dongcheng
7.6.1 Yantai Dongcheng Company Summary
7.6.2 Yantai Dongcheng Business Overview
7.6.3 Yantai Dongcheng Glycosaminochondroitin Supplements Major Product Offerings
7.6.4 Yantai Dongcheng Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.6.5 Yantai Dongcheng Key News & Latest Developments
7.7 Focus Chem
7.7.1 Focus Chem Company Summary
7.7.2 Focus Chem Business Overview
7.7.3 Focus Chem Glycosaminochondroitin Supplements Major Product Offerings
7.7.4 Focus Chem Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.7.5 Focus Chem Key News & Latest Developments
7.8 YBCC
7.8.1 YBCC Company Summary
7.8.2 YBCC Business Overview
7.8.3 YBCC Glycosaminochondroitin Supplements Major Product Offerings
7.8.4 YBCC Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.8.5 YBCC Key News & Latest Developments
7.9 Runxin Biotechnology
7.9.1 Runxin Biotechnology Company Summary
7.9.2 Runxin Biotechnology Business Overview
7.9.3 Runxin Biotechnology Glycosaminochondroitin Supplements Major Product Offerings
7.9.4 Runxin Biotechnology Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.9.5 Runxin Biotechnology Key News & Latest Developments
7.10 ISBA
7.10.1 ISBA Company Summary
7.10.2 ISBA Business Overview
7.10.3 ISBA Glycosaminochondroitin Supplements Major Product Offerings
7.10.4 ISBA Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.10.5 ISBA Key News & Latest Developments
7.11 Huiwen
7.11.1 Huiwen Company Summary
7.11.2 Huiwen Business Overview
7.11.3 Huiwen Glycosaminochondroitin Supplements Major Product Offerings
7.11.4 Huiwen Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.11.5 Huiwen Key News & Latest Developments
7.12 QJBCHINA
7.12.1 QJBCHINA Company Summary
7.12.2 QJBCHINA Business Overview
7.12.3 QJBCHINA Glycosaminochondroitin Supplements Major Product Offerings
7.12.4 QJBCHINA Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.12.5 QJBCHINA Key News & Latest Developments
7.13 Meitek(Synutra International)
7.13.1 Meitek(Synutra International) Company Summary
7.13.2 Meitek(Synutra International) Business Overview
7.13.3 Meitek(Synutra International) Glycosaminochondroitin Supplements Major Product Offerings
7.13.4 Meitek(Synutra International) Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.13.5 Meitek(Synutra International) Key News & Latest Developments
7.14 Hengjie Bio-Pharmaceuticals
7.14.1 Hengjie Bio-Pharmaceuticals Company Summary
7.14.2 Hengjie Bio-Pharmaceuticals Business Overview
7.14.3 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Major Product Offerings
7.14.4 Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.14.5 Hengjie Bio-Pharmaceuticals Key News & Latest Developments
7.15 Nippon Zoki
7.15.1 Nippon Zoki Company Summary
7.15.2 Nippon Zoki Business Overview
7.15.3 Nippon Zoki Glycosaminochondroitin Supplements Major Product Offerings
7.15.4 Nippon Zoki Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.15.5 Nippon Zoki Key News & Latest Developments
7.16 GGI
7.16.1 GGI Company Summary
7.16.2 GGI Business Overview
7.16.3 GGI Glycosaminochondroitin Supplements Major Product Offerings
7.16.4 GGI Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.16.5 GGI Key News & Latest Developments
7.17 Summit Nutritionals
7.17.1 Summit Nutritionals Company Summary
7.17.2 Summit Nutritionals Business Overview
7.17.3 Summit Nutritionals Glycosaminochondroitin Supplements Major Product Offerings
7.17.4 Summit Nutritionals Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.17.5 Summit Nutritionals Key News & Latest Developments
7.18 Sioux Pharm
7.18.1 Sioux Pharm Company Summary
7.18.2 Sioux Pharm Business Overview
7.18.3 Sioux Pharm Glycosaminochondroitin Supplements Major Product Offerings
7.18.4 Sioux Pharm Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.18.5 Sioux Pharm Key News & Latest Developments
7.19 Ruikangda Biochemical
7.19.1 Ruikangda Biochemical Company Summary
7.19.2 Ruikangda Biochemical Business Overview
7.19.3 Ruikangda Biochemical Glycosaminochondroitin Supplements Major Product Offerings
7.19.4 Ruikangda Biochemical Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.19.5 Ruikangda Biochemical Key News & Latest Developments
7.20 Guanglong Biochem
7.20.1 Guanglong Biochem Company Summary
7.20.2 Guanglong Biochem Business Overview
7.20.3 Guanglong Biochem Glycosaminochondroitin Supplements Major Product Offerings
7.20.4 Guanglong Biochem Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.20.5 Guanglong Biochem Key News & Latest Developments
7.21 Pacific Rainbow
7.21.1 Pacific Rainbow Company Summary
7.21.2 Pacific Rainbow Business Overview
7.21.3 Pacific Rainbow Glycosaminochondroitin Supplements Major Product Offerings
7.21.4 Pacific Rainbow Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.21.5 Pacific Rainbow Key News & Latest Developments
7.22 Summit Nutritionals International
7.22.1 Summit Nutritionals International Company Summary
7.22.2 Summit Nutritionals International Business Overview
7.22.3 Summit Nutritionals International Glycosaminochondroitin Supplements Major Product Offerings
7.22.4 Summit Nutritionals International Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.22.5 Summit Nutritionals International Key News & Latest Developments
7.23 Webber Naturals
7.23.1 Webber Naturals Company Summary
7.23.2 Webber Naturals Business Overview
7.23.3 Webber Naturals Glycosaminochondroitin Supplements Major Product Offerings
7.23.4 Webber Naturals Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.23.5 Webber Naturals Key News & Latest Developments
7.24 Mannings
7.24.1 Mannings Company Summary
7.24.2 Mannings Business Overview
7.24.3 Mannings Glycosaminochondroitin Supplements Major Product Offerings
7.24.4 Mannings Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.24.5 Mannings Key News & Latest Developments
7.25 Life Extension
7.25.1 Life Extension Company Summary
7.25.2 Life Extension Business Overview
7.25.3 Life Extension Glycosaminochondroitin Supplements Major Product Offerings
7.25.4 Life Extension Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.25.5 Life Extension Key News & Latest Developments
7.26 Schiff
7.26.1 Schiff Company Summary
7.26.2 Schiff Business Overview
7.26.3 Schiff Glycosaminochondroitin Supplements Major Product Offerings
7.26.4 Schiff Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.26.5 Schiff Key News & Latest Developments
7.27 Doctor’s Best
7.27.1 Doctor’s Best Company Summary
7.27.2 Doctor’s Best Business Overview
7.27.3 Doctor’s Best Glycosaminochondroitin Supplements Major Product Offerings
7.27.4 Doctor’s Best Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.27.5 Doctor’s Best Key News & Latest Developments
7.28 Osteo Bi-Flex
7.28.1 Osteo Bi-Flex Company Summary
7.28.2 Osteo Bi-Flex Business Overview
7.28.3 Osteo Bi-Flex Glycosaminochondroitin Supplements Major Product Offerings
7.28.4 Osteo Bi-Flex Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.28.5 Osteo Bi-Flex Key News & Latest Developments
7.29 Kirkland
7.29.1 Kirkland Company Summary
7.29.2 Kirkland Business Overview
7.29.3 Kirkland Glycosaminochondroitin Supplements Major Product Offerings
7.29.4 Kirkland Glycosaminochondroitin Supplements Sales and Revenue in Global (2018-2023)
7.29.5 Kirkland Key News & Latest Developments
8 Global Glycosaminochondroitin Supplements Production Capacity, Analysis
8.1 Global Glycosaminochondroitin Supplements Production Capacity, 2018-2029
8.2 Glycosaminochondroitin Supplements Production Capacity of Key Manufacturers in Global Market
8.3 Global Glycosaminochondroitin Supplements Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Glycosaminochondroitin Supplements Supply Chain Analysis
10.1 Glycosaminochondroitin Supplements Industry Value Chain
10.2 Glycosaminochondroitin Supplements Upstream Market
10.3 Glycosaminochondroitin Supplements Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Glycosaminochondroitin Supplements Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Glycosaminochondroitin Supplements in Global Market
Table 2. Top Glycosaminochondroitin Supplements Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Glycosaminochondroitin Supplements Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Glycosaminochondroitin Supplements Revenue Share by Companies, 2018-2023
Table 5. Global Glycosaminochondroitin Supplements Sales by Companies, (K Units), 2018-2023
Table 6. Global Glycosaminochondroitin Supplements Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Glycosaminochondroitin Supplements Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Glycosaminochondroitin Supplements Product Type
Table 9. List of Global Tier 1 Glycosaminochondroitin Supplements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Glycosaminochondroitin Supplements Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Glycosaminochondroitin Supplements Sales (K Units), 2018-2023
Table 15. By Type - Global Glycosaminochondroitin Supplements Sales (K Units), 2024-2029
Table 16. By Application – Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Glycosaminochondroitin Supplements Sales (K Units), 2018-2023
Table 20. By Application - Global Glycosaminochondroitin Supplements Sales (K Units), 2024-2029
Table 21. By Region – Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Glycosaminochondroitin Supplements Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Glycosaminochondroitin Supplements Sales (K Units), 2018-2023
Table 25. By Region - Global Glycosaminochondroitin Supplements Sales (K Units), 2024-2029
Table 26. By Country - North America Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Glycosaminochondroitin Supplements Sales, (K Units), 2018-2023
Table 29. By Country - North America Glycosaminochondroitin Supplements Sales, (K Units), 2024-2029
Table 30. By Country - Europe Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Glycosaminochondroitin Supplements Sales, (K Units), 2018-2023
Table 33. By Country - Europe Glycosaminochondroitin Supplements Sales, (K Units), 2024-2029
Table 34. By Region - Asia Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Glycosaminochondroitin Supplements Sales, (K Units), 2018-2023
Table 37. By Region - Asia Glycosaminochondroitin Supplements Sales, (K Units), 2024-2029
Table 38. By Country - South America Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Glycosaminochondroitin Supplements Sales, (K Units), 2018-2023
Table 41. By Country - South America Glycosaminochondroitin Supplements Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Glycosaminochondroitin Supplements Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Glycosaminochondroitin Supplements Sales, (K Units), 2024-2029
Table 46. Suntory Company Summary
Table 47. Suntory Glycosaminochondroitin Supplements Product Offerings
Table 48. Suntory Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Suntory Key News & Latest Developments
Table 50. Orihiro Group Company Summary
Table 51. Orihiro Group Glycosaminochondroitin Supplements Product Offerings
Table 52. Orihiro Group Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Orihiro Group Key News & Latest Developments
Table 54. ANXIN Company Summary
Table 55. ANXIN Glycosaminochondroitin Supplements Product Offerings
Table 56. ANXIN Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. ANXIN Key News & Latest Developments
Table 58. WanTuMing Biological Company Summary
Table 59. WanTuMing Biological Glycosaminochondroitin Supplements Product Offerings
Table 60. WanTuMing Biological Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. WanTuMing Biological Key News & Latest Developments
Table 62. TSI Group Company Summary
Table 63. TSI Group Glycosaminochondroitin Supplements Product Offerings
Table 64. TSI Group Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. TSI Group Key News & Latest Developments
Table 66. Yantai Dongcheng Company Summary
Table 67. Yantai Dongcheng Glycosaminochondroitin Supplements Product Offerings
Table 68. Yantai Dongcheng Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Yantai Dongcheng Key News & Latest Developments
Table 70. Focus Chem Company Summary
Table 71. Focus Chem Glycosaminochondroitin Supplements Product Offerings
Table 72. Focus Chem Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Focus Chem Key News & Latest Developments
Table 74. YBCC Company Summary
Table 75. YBCC Glycosaminochondroitin Supplements Product Offerings
Table 76. YBCC Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. YBCC Key News & Latest Developments
Table 78. Runxin Biotechnology Company Summary
Table 79. Runxin Biotechnology Glycosaminochondroitin Supplements Product Offerings
Table 80. Runxin Biotechnology Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Runxin Biotechnology Key News & Latest Developments
Table 82. ISBA Company Summary
Table 83. ISBA Glycosaminochondroitin Supplements Product Offerings
Table 84. ISBA Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. ISBA Key News & Latest Developments
Table 86. Huiwen Company Summary
Table 87. Huiwen Glycosaminochondroitin Supplements Product Offerings
Table 88. Huiwen Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Huiwen Key News & Latest Developments
Table 90. QJBCHINA Company Summary
Table 91. QJBCHINA Glycosaminochondroitin Supplements Product Offerings
Table 92. QJBCHINA Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. QJBCHINA Key News & Latest Developments
Table 94. Meitek(Synutra International) Company Summary
Table 95. Meitek(Synutra International) Glycosaminochondroitin Supplements Product Offerings
Table 96. Meitek(Synutra International) Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Meitek(Synutra International) Key News & Latest Developments
Table 98. Hengjie Bio-Pharmaceuticals Company Summary
Table 99. Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Product Offerings
Table 100. Hengjie Bio-Pharmaceuticals Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Hengjie Bio-Pharmaceuticals Key News & Latest Developments
Table 102. Nippon Zoki Company Summary
Table 103. Nippon Zoki Glycosaminochondroitin Supplements Product Offerings
Table 104. Nippon Zoki Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Nippon Zoki Key News & Latest Developments
Table 106. GGI Company Summary
Table 107. GGI Glycosaminochondroitin Supplements Product Offerings
Table 108. GGI Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. GGI Key News & Latest Developments
Table 110. Summit Nutritionals Company Summary
Table 111. Summit Nutritionals Glycosaminochondroitin Supplements Product Offerings
Table 112. Summit Nutritionals Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Summit Nutritionals Key News & Latest Developments
Table 114. Sioux Pharm Company Summary
Table 115. Sioux Pharm Glycosaminochondroitin Supplements Product Offerings
Table 116. Sioux Pharm Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Sioux Pharm Key News & Latest Developments
Table 118. Ruikangda Biochemical Company Summary
Table 119. Ruikangda Biochemical Glycosaminochondroitin Supplements Product Offerings
Table 120. Ruikangda Biochemical Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Ruikangda Biochemical Key News & Latest Developments
Table 122. Guanglong Biochem Company Summary
Table 123. Guanglong Biochem Glycosaminochondroitin Supplements Product Offerings
Table 124. Guanglong Biochem Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Guanglong Biochem Key News & Latest Developments
Table 126. Pacific Rainbow Company Summary
Table 127. Pacific Rainbow Glycosaminochondroitin Supplements Product Offerings
Table 128. Pacific Rainbow Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Pacific Rainbow Key News & Latest Developments
Table 130. Summit Nutritionals International Company Summary
Table 131. Summit Nutritionals International Glycosaminochondroitin Supplements Product Offerings
Table 132. Summit Nutritionals International Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 133. Summit Nutritionals International Key News & Latest Developments
Table 134. Webber Naturals Company Summary
Table 135. Webber Naturals Glycosaminochondroitin Supplements Product Offerings
Table 136. Webber Naturals Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 137. Webber Naturals Key News & Latest Developments
Table 138. Mannings Company Summary
Table 139. Mannings Glycosaminochondroitin Supplements Product Offerings
Table 140. Mannings Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 141. Mannings Key News & Latest Developments
Table 142. Life Extension Company Summary
Table 143. Life Extension Glycosaminochondroitin Supplements Product Offerings
Table 144. Life Extension Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 145. Life Extension Key News & Latest Developments
Table 146. Schiff Company Summary
Table 147. Schiff Glycosaminochondroitin Supplements Product Offerings
Table 148. Schiff Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 149. Schiff Key News & Latest Developments
Table 150. Doctor's Best Company Summary
Table 151. Doctor's Best Glycosaminochondroitin Supplements Product Offerings
Table 152. Doctor's Best Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 153. Doctor's Best Key News & Latest Developments
Table 154. Osteo Bi-Flex Company Summary
Table 155. Osteo Bi-Flex Glycosaminochondroitin Supplements Product Offerings
Table 156. Osteo Bi-Flex Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 157. Osteo Bi-Flex Key News & Latest Developments
Table 158. Kirkland Company Summary
Table 159. Kirkland Glycosaminochondroitin Supplements Product Offerings
Table 160. Kirkland Glycosaminochondroitin Supplements Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 161. Kirkland Key News & Latest Developments
Table 162. Glycosaminochondroitin Supplements Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 163. Global Glycosaminochondroitin Supplements Capacity Market Share of Key Manufacturers, 2021-2023
Table 164. Global Glycosaminochondroitin Supplements Production by Region, 2018-2023 (K Units)
Table 165. Global Glycosaminochondroitin Supplements Production by Region, 2024-2029 (K Units)
Table 166. Glycosaminochondroitin Supplements Market Opportunities & Trends in Global Market
Table 167. Glycosaminochondroitin Supplements Market Drivers in Global Market
Table 168. Glycosaminochondroitin Supplements Market Restraints in Global Market
Table 169. Glycosaminochondroitin Supplements Raw Materials
Table 170. Glycosaminochondroitin Supplements Raw Materials Suppliers in Global Market
Table 171. Typical Glycosaminochondroitin Supplements Downstream
Table 172. Glycosaminochondroitin Supplements Downstream Clients in Global Market
Table 173. Glycosaminochondroitin Supplements Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Glycosaminochondroitin Supplements Segment by Type in 2022
Figure 2. Glycosaminochondroitin Supplements Segment by Application in 2022
Figure 3. Global Glycosaminochondroitin Supplements Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Glycosaminochondroitin Supplements Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Glycosaminochondroitin Supplements Revenue, 2018-2029 (US$, Mn)
Figure 7. Glycosaminochondroitin Supplements Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Glycosaminochondroitin Supplements Revenue in 2022
Figure 9. By Type - Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 11. By Type - Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 12. By Type - Global Glycosaminochondroitin Supplements Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 15. By Application - Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 16. By Application - Global Glycosaminochondroitin Supplements Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Glycosaminochondroitin Supplements Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 20. By Region - Global Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 21. By Country - North America Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 22. By Country - North America Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 23. US Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 28. Germany Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 29. France Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 37. China Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 41. India Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 43. By Country - South America Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 44. Brazil Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Glycosaminochondroitin Supplements Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Glycosaminochondroitin Supplements Sales Market Share, 2018-2029
Figure 48. Turkey Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Glycosaminochondroitin Supplements Revenue, (US$, Mn), 2018-2029
Figure 52. Global Glycosaminochondroitin Supplements Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Glycosaminochondroitin Supplements by Region, 2022 VS 2029
Figure 54. Glycosaminochondroitin Supplements Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 免疫サポートビタミン&サプリメントのグローバル市場展望 2023年-2029年：ビタミン&ミネラルサプリメント、ハーブサプリメント、プロバイオティクスサプリメント、アミノ酸&タンパク質、オメガ3脂肪酸、その他
  • 關心蘇河膠廠のグローバル市場展望 2023年-2029年：0.35g/カプセル、0.25g/カプセル
  • ペニシリンVカリウムのグローバル市場展望 2023年-2029年：錠剤、カプセル、その他
  • プロゲステロン薬のグローバル市場展望 2023年-2029年：カプセル、錠剤、その他
  • トラマドール医薬品のグローバル市場展望 2023年-2029年：錠剤、カプセル、液体、懸濁液、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14349 )"グリコサミノコンドロイチン・サプリメントのグローバル市場展望 2023年-2029年：カプセル、錠剤、その他" (英文：Glycosaminochondroitin Supplements Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。